Pathogenesis of genital tract disease due to Chlamydia trachomatis

Journal of Infectious Diseases

Volumn 201, Issue SUPPL. 2, 2010, Pages

  Darville, Toni ^a   Hiltke, Thomas J ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TOLL LIKE RECEPTOR 2;

CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE MARKER; EPITHELIUM CELL; GENITAL TRACT INFECTION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REINFECTION; REVIEW; TH1 CELL; TISSUE INJURY; ANIMAL; CELLULAR IMMUNITY; DISEASE PREDISPOSITION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, CELLULAR;

EID: 77953102683     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652397     Document Type: Review

References (83)

1. Kiviat NB, Wolner-Hanssen P, Eschenbach DA, et al. Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 1990;14(2):167-175. (Pubitemid 20039012)
2. Kelly KA, Rank RG. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun 1997;65(12): 5198-5208.
3. Morrison SG, Morrison RP. In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infect Immun 2000;68(5):2870-2879.
4. Darville T, Andrews CW Jr, Laffoon KK, Shymasani W, Kishen LR, Rank RG. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun 1997;65(8):3065-3073. (Pubitemid 27342379)
5. Soloff BL, Rank RG, Barron AL. Ultrastructural studies of chlamydial infection in guinea pig urogenital tract. J Comp Pathol 1982; 92: 547-558. (Pubitemid 13168724)
6. Rank RG, Barron AL. Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs. Infect Immun 1983;41(2):876-879. (Pubitemid 13074657)
7. Ramsey KH, Rank RG. Resolution of chlamydial genital infection with antigen-specific T- lymphocyte lines. Infect Immun 1991;59(3): 925-931.
8. Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for major histocompatibility complex dass IIrestricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995;63(12):4661-4668.
9. Rank RG, Sanders MM. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am J Pathol 1992;140(4):927-936.
10. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 1999;5(5):433-447.
11. van Valkengoed IG, Morre SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes-implications for costeffectiveness analyses. Int J Epidemiol 2004;33(2):416-425.
12. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted diseases: overview and estimates. Geneva: world Health Organization, 2001:1-34.
13. Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003;11:44-51.
14. Rasmussen SJ, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997;99(1):77-87.
15. Molano M, Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5year follow-up study. J Infect Dis 2005; 191(6):907-916.
16. Burstein GR, Gaydos CA, Diener-West M., Howell MR, Zenilman JM, Quinn TC. Incident Chlamydia trachomatis infections among innercity adolescent females [see comments]. JAMA 1998;280(6):521-526.
17. Cain TK, Rank RG. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1995;63(5):1784-1789.
18. Perry LL, Feilzer K, Caldwell HD. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and independent pathways. J Immunol 1997; 158(7):3344-3352.
19. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE, Byrne GI. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun 1997; 65 (6): 2145-2152.
20. Morrison SG, Su H, Caldwell HD, Morrison RP. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun 2000;68(12): 6979-6987.
21. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005;5(2):149-161.
22. Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985;7(6):717-725.
23. Watkins NG, Hadlow WJ, Moos AB, Caldwell HD. Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial conjunctivitis in guinea pigs. Proc Natl Acad Sci USA 1986;83:7480-7484.
24. Morrison RP, Lyng K, Caldwell HD. Chlamydial disease pathogenesis: ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med 1989; 169(3):663-675. (Pubitemid 19250693)
25. Rank RG, Dascher C, Bowlin AK, Bavoil PM. Systemic immunization with Hsp60 alters the development of chlamydial ocular disease. Invest Ophthalmol Vis Sci 1995;36(7):1344-1351.
26. Peeling RW, Kimani J, Plummer F et al. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis 1997; 175(5):1153-1158.
27. Toye B, Laferrière C, Claman P, Jessamine P, Peeling R. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis 1993;168:1236-1240. (Pubitemid 23317141)
28. Ness RB, Soper DE, Richter HE, et al. Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis 2008;35(2):129-135.
29. Cohen CR, Koochesfahani KM, Meier AS, et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-gamma. J Infect Dis 2005; 192(4):591-599.
30. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun 1997;65(6):2175-2182.
31. Rank RG, Sanders MM., Patton DL. Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis. Sex Transm Dis 1995;22(1);48-54.
32. Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 1993; 61: 4569-4574. (Pubitemid 23320507)
33. Hvid M, Baczynska A, Deleuran B, et al. Interleukin-1 is the initiator of fallopian tube destruction during Chlamydia trachomatis infection. Cell Microbiol 2007;9:2795-2803.
34. Ault KA, Tawfik OW, Smith-King MM, Gunter J, Terranova PF. Tumor necrosis factor-alpha response to infection with Chlamydia trachomatis in human fallopian tube organ culture. Am J Obstet Gynecol 1996; 175(5):1242-1245. (Pubitemid 26398985)
35. Kelly KA, Natarajan S, Ruther P, Wisse A, Chang MH, Ault KA. Chlamydia trachomatis infection induces mucosal addressin cell adhesion molecule-1 and vascular cell adhesion molecule-1, providing an immunologic link between the fallopian tube and other mucosal tissues. J Infect Dis 2001;184(7):885-891.
36. Belay T, Eko FO, Ananaba GA et al. Chemokine and chemokine receptor dynamics during genital chlamydial infection. Infect Immun 2002; 70(2):844-850. (Pubitemid 34083848)
37. Darville T, Lafoon KK, Kishen LR, Rank RG. Tumor necrosis factoralpha activity in genital tract secretions of guinea pigs infected with chlamydiae. Infect Immun 1995;63:4675-4681.
38. Shah AA, Schripsema JH, Imtiaz MT, et al. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis 2005;32(1):49-56.
39. Ramsey KH, Sigar IM., Schripsema JH, Shaba N, Cohoon KP. Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infect Immun 2005;73(10):6962-6973.
40. Darville T, Andrews CW, Jr., Sikes JD, Fraley PL, Rank RG. Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect Immun 2001;69(6):3556-3561. (Pubitemid 32493267)
41. Ramsey KH, Sigar IM, Rana SV, Gupta J, Holland SM, Byrne GI. Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals. Infect Immun 2001;69(12):7374-7379.
42. Ault KA, Kelly KA, Ruther PE, et al. Chlamydia trachomatis enhances the expression of matrix metalloproteinases in an in vitro model of the human fallopian tube infection. Am J Obstet Gynecol 2002; 187(5): 1377-1383.
43. Wiesenfeld HC, Heine RP, Krohn MA, et al. Association between elevated neutrophil defensin levels and endometritis. J Infect Dis 2002; 186(6):792-797.
44. Wyrick PB, Knight ST, Paul TR, Rank RG, Barbier CS. Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil Chemotaxis. J Infect Dis 1999;179(4):954-966.
45. Ito JI Jr, Lyons JM, Airo-Brown LP. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun 1990;58(6):2021-2023.
46. Tuffrey M, Falder P, Taylor-Robinson D. Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br J Exp Pathol 1982; 63(5):539-546. (Pubitemid 13250649)
47. O'Connell CM, Ionova IA, Quayle AJ, Visintin A, Ingalls RR. Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions: evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen. J Biol Chem 2006;281(3):1652-1659.
48. Darville T, O'Neill JM., Andrews CW Jr, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003;171(11):6187-6197. (Pubitemid 37467242)
49. O'Connell CM, Ingalls RR, Andrews CW Jr, Skurlock AM, Darville T. Plasmid-deficient Chlamydia muridarum fail to induce immune pa thology and protect against oviduct disease. J Immunol 2007; 179(6): 4027-4034.
50. Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol 2005; 174(2): 992-1002.
51. Pioli PA, Amiel E, Schaefer TM, Connolly JE, Wira CR, Guyre PM. Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 2004; 72(10): 5799-5806. (Pubitemid 39303691)
52. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol 2002; 168(5):2424-2432.
53. Kiviat NB, Paavonen JA, Wolner-Hanssen P, et al. Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Hum Pathol 1990; 21(8):831-837.
54. Rank RG, Bowlin AK, Kelly KA. Characterization of lymphocyte response in the female genital tract during ascending chlamydial genital infection in the guinea pig model. Infect Immun 2000; 68(9): 5293-5298.
55. Patton DL, Kuo CC. Histopathology of Chlamydia trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket model. J Reprod Fertil 1989;85(2):647-656.
56. Rank RG, Sanders MM, Patton DL. Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis. Sex Transm Dis 1995;22(1):48-54.
57. Lichtenwalner AB, Patton DL, Van Voorhis WC, Sweeney YT, Kuo CC. Heat shock protein 60 is the major antigen which stimulates delayedtype hypersensitivity reaction in the macaque model of Chlamydia trachomatis salpingitis. Infect Immun 2004;72(2):1159-1161.
58. Kimani J, Maclean IW, Bwayo JJ, et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 1996;173(6):1437-1444.
59. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LE, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997;176:103-107.
60. Bakken IJ, Skjeldestad FE, Lydersen S, Nordbo SA. Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis. Sex Transm Dis 2007;34(10):739-743.
61. Rank RG, Batteiger BE, Soderberg LS. Susceptibility to reinfection after a primary chlamydial genital infection. Infect Immun 1988; 56(9): 2243-2249.
62. Rank RG, Soderberg LS, Sanders MM, Batteiger BE. Role of cell-mediated immunity in the resolution of secondary chlamydial genital infection in guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 1989;57(3):706-710.
63. Batteiger BE, Rank RG. Analysis of the humoral immune response to chlamydial genital infection in guinea pigs. Infect Immun 1987; 55(8): 1767-1773.
64. Rank RG, Bowlin AK, Kelly KA. Characterization of lymphocyte response in the female genital tract during ascending Chlamydial genital infection in the guinea pig model. Infect Immun 2000; 68(9): 5293-5298.
65. Debattista J, Timms P, Allan J, Allan J. Reduced levels of gammainterferon secretion in response to chlamydial 60 kDa heat shock protein amongst women with pelvic inflammatory disease and a history of repeated Chlamydia trachomatis infections. Immunol Lett 2002; 81(3):205-210.
66. Kinnunen A, Surcel H, Lehtinen M, et al. HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomaris-related tubal factor infertility: a case-control study. Hum Reprod 2002;17(8):2073-2078.
67. Agrawal T, Gupta R, Dutta R et al. Protective or pathogenic immune response to genital chlamydial infection in women-a possible role of cytokine secretion profile of cervical mucosal cells. Clin Immunol 2009;130:347-354.
68. Barr EL, Ouburg S, Igietseme JU, et al. Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion. J Microbiol Immunol Infect 2005; 38(4): 244-254.
69. Dubin PJ, Kolls JK. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007;292(2):L519-L528.
70. Koenders MI, Kolls JK, Oppers-Walgreen B, et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum 2005;52(10):3239-3247.
71. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21(4)467-476.
72. Cruz A, Khader SA, Torrado E, et al. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006; 177(3):1416-1420.
73. Benwell RK, Lee DR. Essential and synergistic roles of IL1 and IL6 in human Th 17 differentiation directed by TLR ligand-activated dendritic cells. Clin Immunol 2010;134:178-187.
74. Morre SA, Murillo LS, Bruggeman CA, Pena AS. The role that the functional Asp299Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associted tubal infertility. J Infect Dis 2003; 187(2):341-342.
75. Ouburg S, Spaargaren J, den Hartog JE, et al. The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology. BMC Infect Dis 2005; 5:114.
76. Murillo LS, Land JA, Pleijster J, Bruggeman CA, Pena AS, Morre SA. Interleukin-1B (IL-1B) andinterleukin-1 receptor antagonist (IL-IRN) gene polymorphisms are not associated with tubal pathology and Chlamydia trachomatis-related tubal factor subfertility. Hum Reprod 2003; 18(11):2309-2314.
77. Sziller I, Babula O, Ujhazy A, et al. Chlamydia trachomatis infection, Fallopian tube damage and a mannose-binding lectin codon 54 gene polymorphism. Hum Reprod 2007;22(7):1861-1865.
78. Swanson AF, Ezekowitz RA, Lee A, Kuo CC. Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun 1998;66(4):1607-1612.
79. Peipert JF, Boardman L, Hogan JW, Sung J, Mayer KH. Laboratory evaluation of acute upper genital tract infection. Obstet Gynecol 1996;87:730-736.
80. Peeling RW, Kimani J, Plummer F, et al. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis 1997; 175(5):1153-1158.
81. Peeling RW, Patton DL, Cosgrove Sweeney YT et al. Antibody response to the chlamydial heat-shock protein 60 in an experimental model of chronic pelvic inflammatory disease in monkeys (Macaca nemestrina). J Infect Dis 1999; 180(3):774-779.
82. Pal S, Peterson EM, De La Maza LM. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun 2005;73(12):8153-8160.
83. Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun 2007;75(2):666-676.